BlackRock Investment Management’s Alder Biopharmaceuticals ALDR Stock Holding History

BlackRock Investment Management’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$3.8M	Sell	182,686 -5,984	-3%	-$156K	﹤0.01%	1779
2016 Q3	$6.18M	Buy	188,670 +1,610	+0.9%	+$49K	0.01%	1335
2016 Q2	$4.67M	Buy	187,060 +93,980	+101%	+$2.54M	0.01%	1480
2016 Q1	$2.28M	Sell	93,080 -16,745	-15%	-$388K	﹤0.01%	1899
2015 Q4	$3.63M	Buy	109,825 +1,008	+0.9%	+$34.1K	﹤0.01%	1624
2015 Q3	$3.56M	Buy	108,817 +1,519	+1%	+$64.6K	﹤0.01%	1620
2015 Q2	$5.68M	Buy	107,298 +42,441	+65%	+$1.54M	0.01%	1400
2015 Q1	$1.87M	Buy	64,857 +24,677	+61%	+$677K	﹤0.01%	2073
2014 Q4	$1.17M	Buy	40,180 +480	+1%	+$8.62K	﹤0.01%	2440
2014 Q3	$503K	Buy	39,700 +115	+0.3%	+$1.74K	﹤0.01%	2973
2014 Q2	$794K	Buy	+39,585	New	+$557K	﹤0.01%	2777

Other funds holding ALDR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock Investment Management's ALDR Position: Q4 2016 in Review

BlackRock Investment Management reduced its Alder Biopharmaceuticals (ALDR) stake by 3.2% in Q4 2016, selling an estimated $156K and leaving 182,686 shares worth $3.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1779.

BlackRock Investment Management first reported a position in ALDR in Q2 2014 and has held it in 11 quarters since. The position peaked at $6.18M in Q3 2016. 145 funds tracked by Wall St. Rank hold ALDR as of Q4 2016.

BlackRock Investment Management held 182,686 shares of Alder Biopharmaceuticals worth $3.8M as of Q4 2016.
BlackRock Investment Management sold 5,984 Alder Biopharmaceuticals shares in Q4 2016, an estimated $156K.
Alder Biopharmaceuticals made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1779 holding.
BlackRock Investment Management first reported a position in Alder Biopharmaceuticals in Q2 2014 and has held it in 11 quarters since.
BlackRock Investment Management's Alder Biopharmaceuticals position peaked at $6.18M in Q3 2016.
145 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.